136 related articles for article (PubMed ID: 32827448)
21. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
Verhamme IM; Bock PE; Jackson CM
J Biol Chem; 2004 Mar; 279(11):9785-95. PubMed ID: 14701814
[TBL] [Abstract][Full Text] [Related]
22. Rapid changes in the exon/intron structure of a mammalian thrombin inhibitor gene.
Kamp PB; Ragg H
Gene; 1999 Mar; 229(1-2):137-44. PubMed ID: 10095113
[TBL] [Abstract][Full Text] [Related]
23. Altering heparin cofactor II at VAL439 (P6) either impairs inhibition of thrombin or confers elastase resistance.
Cunningham MA; Bhakta V; Sheffield WP
Thromb Haemost; 2002 Jul; 88(1):89-97. PubMed ID: 12152684
[TBL] [Abstract][Full Text] [Related]
24. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.
Baglin TP; Carrell RW; Church FC; Esmon CT; Huntington JA
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11079-84. PubMed ID: 12169660
[TBL] [Abstract][Full Text] [Related]
26. Sulfated polysaccharide from the leaves of Artemisia Princeps activates heparin cofactor II independently of the Lys173 and Arg189 residues of heparin cofactor II.
Hayashi T; Hayakawa Y; Hayashi T; Sasaki H; Sakuragawa N
Thromb Res; 1997 Jul; 87(1):105-12. PubMed ID: 9253805
[TBL] [Abstract][Full Text] [Related]
27. Heparin cofactor II (RbHCII) from rock bream (Oplegnathus fasciatus): molecular characterization, cloning and expression analysis.
Umasuthan N; Whang I; Lee Y; Lee S; Kim Y; Kim H; Jung SJ; Oh MJ; Choi CY; Yeo SY; Lee SJ; Lee J
Fish Shellfish Immunol; 2011 Jan; 30(1):194-208. PubMed ID: 20951808
[TBL] [Abstract][Full Text] [Related]
28. Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis.
Corral J; Aznar J; Gonzalez-Conejero R; Villa P; Miñano A; Vayá A; Carrell RW; Huntington JA; Vicente V
Circulation; 2004 Sep; 110(10):1303-7. PubMed ID: 15337701
[TBL] [Abstract][Full Text] [Related]
29. Deletion mutagenesis of heparin cofactor II: defining the minimum size of a thrombin inhibiting serpin.
Sheffield WP; Blajchman MA
FEBS Lett; 1995 May; 365(2-3):189-92. PubMed ID: 7781777
[TBL] [Abstract][Full Text] [Related]
30. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
Blinder MA; Tollefsen DM
J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
[TBL] [Abstract][Full Text] [Related]
31. Serpin-glycosaminoglycan interactions.
Rein CM; Desai UR; Church FC
Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
[TBL] [Abstract][Full Text] [Related]
32. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
[TBL] [Abstract][Full Text] [Related]
33. Molecular mapping of the thrombin-heparin cofactor II complex.
Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC
J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227
[TBL] [Abstract][Full Text] [Related]
34. Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis.
Rau JC; Mitchell JW; Fortenberry YM; Church FC
Semin Thromb Hemost; 2011 Jun; 37(4):339-48. PubMed ID: 21805439
[TBL] [Abstract][Full Text] [Related]
35. Mannose 2, 3, 4, 5, 6-
Bano S; Khan AB; Fatima S; Rashid Q; Prakash A; Gupta N; Ahmad I; Ansari S; Lynn AM; Abid M; Jairajpuri MA
J Biomol Struct Dyn; 2023 Jun; 41(9):3717-3727. PubMed ID: 35343865
[TBL] [Abstract][Full Text] [Related]
36. The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation.
Parker KA; Tollefsen DM
J Biol Chem; 1985 Mar; 260(6):3501-5. PubMed ID: 3838315
[TBL] [Abstract][Full Text] [Related]
37. Enhanced thrombin sensitivity of a factor VIII-heparin cofactor II hybrid.
Voorberg J; van Stempvoort G; Bos JM; Mertens K; van Mourik JA; Donath MJ
J Biol Chem; 1996 Aug; 271(35):20985-8. PubMed ID: 8702860
[TBL] [Abstract][Full Text] [Related]
38. Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.
Verhamme IM
Anal Biochem; 2012 Feb; 421(2):489-98. PubMed ID: 22206940
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of heparin cofactor II anticoagulant activity.
Bauman SJ; Church FC
J Biol Chem; 1999 Dec; 274(49):34556-65. PubMed ID: 10574918
[TBL] [Abstract][Full Text] [Related]
40. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
Myles T; Church FC; Whinna HC; Monard D; Stone SR
J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
